Clinical Trial Update: A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis. [Phase 1, Phase 2]

View source ↗

Summary

This document reports an early-stage clinical trial evaluating NB-4746 for amyotrophic lateral sclerosis, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NB-4746

Snippet

Sponsor: Nura Bio | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING